MEA Q4 2023

As 2023 gets ready to draw to a close, we are thrilled to share with you the award-winning enterprises that are truly triumphing across the MEA business realm. In the face of ongoing global challenges, these businesses show unparalleled resilience and adaptability, steering the course toward continued growth and success – whether pharmaceutical enterprise, sustainable energy solutions provider, marketing and promotions company, and more. Indeed, throughout the year, we have witnessed dynamic shifts in market trends, technological advancements, and sustainable business practices, yet the MEA region proves itself to be a crucible of innovation and entrepreneurship. Visionaries from across its industries have become beacons of excellence, their innovative solutions transcending borders and possibilities. A perfect example is our front cover feature, INNOVIA Biobank and its CEO, Dr Mohannad Al-Ghazo, whom we have named our Most Visionary Healthcare Diversification CEO 2023. In light of his recognition, we delve into what makes INNOVIA Biobank the groundbreaking medical and research facility it is. Leading the modern transformation of medicine, it houses the MEA region’s premier laboratory facility dedicated to biobanking services. Now, as we get ready to conclude this chapter that has been 2023, I wish you a reflective and inspiring read and a prosperous quarter ahead. In the meantime, I look forward to welcoming you back again soon for our Q1 2024 issue. Rebecca Scotland, Editor www.mea-markets.com Welcome to the Q4 issue of MEA Markets magazine. As always, we are dedicated to providing our readers with all of the latest news and features from across the Middle East and Africa. AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.

RkJQdWJsaXNoZXIy MTUyMDQwMA==